BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI | BioFabUSA will attend Meeting on the Mesa 2025, one of the premier partnering events for the cell and gene therapy sector, taking place October 6–8 in Phoenix, AZ. This event provides a unique platform for ARMI to engage with leading biotechnology companies, investors, and regulatory experts.
As regenerative medicine moves from the lab to commercial scale, events like Meeting on the Mesa are essential for fostering the connections and knowledge-sharing that drive progress. ARMI will attend the 2025 event to strengthen partnerships, share manufacturing capabilities, and highlight our national network’s role in accelerating translation of breakthrough therapies.
ARMI’s team will:
Through its participation, ARMI aims to amplify its mission to make scalable, cost-effective biomanufacturing a reality for curative therapies. We look forward to exchanging insights with peers who are committed to transforming lives through biotechnology.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
